Tyco Healthcare to separate from parent co., get new name

Tyco Healthcare announced that it will now be known as Covidien once the division separates from parent company Tyco International this spring and becomes an independent, publicly-traded company.
 
Tyco Healthcare is a global manufacturer and distributor of medical products, with annual sales of nearly $10 billion. Its product portfolio includes disposable medical supplies, monitoring equipment, medical instruments and bulk analgesic pharmaceuticals.
 
The Covidien brand will be the umbrella identity for brand names such as Autosuture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture, and Valleylab.
 
The healthcare company employs over 43,000 people worldwide. As an independent, the company plans to embark on a new direction that focuses exclusively on healthcare and benefits from increased flexibility to invest in innovation and organic growth, the company said.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup